Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Wischik

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
The Journal of Nutrition, Health & Aging|March 21, 2009
Challenges in the conduct of disease-modifying trials in AD: practical experience from a phase 2 trial of Tau-aggregation inhibitor therapyC Wischik, R Staff
Lancet (London, England)|April 10, 1993
Mitochondrial function in Alzheimer's diseaseJ M Cooper, C Wischik, A H Schapira
Annals of Neurology|October 8, 1999
Association between Alzheimer's disease and the NOS3 geneM Dahiyat, A Cumming, C Harrington, et al.
European Journal of Human Genetics : EJHG|September 14, 1999
Evaluation of polymorphisms in the presenilin-1 gene and the butyrylcholinesterase gene as risk factors in sporadic Alzheimer's diseaseL Tilley, K Morgan, J Grainger, et al.
Human Genetics|January 1, 1997
Microsatellite polymorphism of the alpha 1-antichymotrypsin gene locus associated with sporadic Alzheimer's diseaseK Morgan, L Morgan, K Carpenter, et al.
Neurobiology of Aging|March 1, 1992
Immunological characterization of the region of tau protein that is bound to Alzheimer paired helical filamentsC B Caputo, C Wischik, M Novak, et al.
Annals of the New York Academy of Sciences|May 20, 2000
Neuropathological findings in the very old. Results from the first 101 brains of a population-based longitudinal study of dementing disordersJ H Xuereb, C Brayne, C Dufouil, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
The Journal of Nutrition, Health & Aging|March 21, 2009
Challenges in the conduct of disease-modifying trials in AD: practical experience from a phase 2 trial of Tau-aggregation inhibitor therapyC Wischik, R Staff
Lancet (London, England)|April 10, 1993
Mitochondrial function in Alzheimer's diseaseJ M Cooper, C Wischik, A H Schapira
Annals of Neurology|October 8, 1999
Association between Alzheimer's disease and the NOS3 geneM Dahiyat, A Cumming, C Harrington, et al.
European Journal of Human Genetics : EJHG|September 14, 1999
Evaluation of polymorphisms in the presenilin-1 gene and the butyrylcholinesterase gene as risk factors in sporadic Alzheimer's diseaseL Tilley, K Morgan, J Grainger, et al.
Human Genetics|January 1, 1997
Microsatellite polymorphism of the alpha 1-antichymotrypsin gene locus associated with sporadic Alzheimer's diseaseK Morgan, L Morgan, K Carpenter, et al.
Neurobiology of Aging|March 1, 1992
Immunological characterization of the region of tau protein that is bound to Alzheimer paired helical filamentsC B Caputo, C Wischik, M Novak, et al.
Annals of the New York Academy of Sciences|May 20, 2000
Neuropathological findings in the very old. Results from the first 101 brains of a population-based longitudinal study of dementing disordersJ H Xuereb, C Brayne, C Dufouil, et al.
Pageof 1